Serum levels of IL-6, IL-10, IL-12, IL-17 and IFN-γ and their association with markers of bone metabolism in vitamin d-deficient female students

Inflammation

Volumn 36, Issue 1, 2013, Pages 164-168

  Jamali, Zahra ^a   Arababadi, Mohammad Kazemi ^b   Asadikaram, Gholamreza ^a,c  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

25 hydroxyl vitamin D3; bone metabolism markers; cytokines; female students

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; CALCIFEDIOL; CALCIUM; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 6; PARATHYROID HORMONE; PHOSPHORUS;

ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE METABOLISM; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE PRODUCTION; DESCRIPTIVE RESEARCH; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; MACROPHAGE; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE AND BONES; CALCIUM; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-17; INTERLEUKIN-6; INTERLEUKINS; IRAN; OSTEOGENESIS; PARATHYROID HORMONE; PHOSPHORUS; TH17 CELLS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84872934189     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9531-9     Document Type: Article

References (37)

1. Gordon, C.M., K.C. DePeter, H.A. Feldman, et al. 2004. Prevalence of vitamin D deficiency among healthy adolescents. Archives of Pediatrics & Adolescent Medicine 158: 531-537. (Pubitemid 38720483)
2. Holick, M.F. 2004. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. American Journal of Clinical Nutrition 80: 1678S-1688S.
3. Holick, M.F. 2004. Vitamin D: Importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. American Journal of Clinical Nutrition 79: 362-371. (Pubitemid 41115577)
4. Arababadi, M.K., M. Reza Mirzaei, S.M. Ali Sajadi, et al. 2012. Interleukin (IL)-10 gene polymorphisms are associated with type 2 diabetes with and without nephropathy: A study of patients from the southeast region of Iran. Inflammation 35: 797-802.
5. Mak, G., and N.A. Hanania. 2011. Vitamin D and asthma. Current Opinion in Pulmonary Medicine 17: 1-5.
6. 3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis. PLoS One 5: e12925.
7. Schwalfenberg, G.K. 2011. A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Molecular Nutrition & Food Research 55: 96-108.
8. Kazemi Arababadi, M. 2012. Interleukin-4 gene polymorphisms in type 2 diabetic patients with nephropathy. Iranian Journal of Kidney Diseases 4: 302-306.
9. Gozalbo, D., and M.L. Gil. 2009. IFN-gamma in Candida albicans infections. Frontiers in Bioscience 14: 1970-1978.
10. Kurnatowski, P., and A.J. Kurnatowska. 2010. The immune response to fungal infections. WiadomoÅci Parazytologiczne 56: 23-27.
11. Queiroz-Junior CM, Silva MJ, Correa JD, et al. 2010. A controversial role for IL-12 in immune response and bone resorption at apical periodontal sites. Clinical and Developmental Immunology 327417.
12. Jilka, R.L., G. Hangoc, G. Girasole, et al. 1992. Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 257: 88-91.
13. Gaffen, S.L. 2004. Biology of recently discovered cytokines: Interleukin-17 - a unique inflammatory cytokine with roles in bone biology and arthritis. Arthritis Research & Therapy 6: 240-247. (Pubitemid 39490012)
14. Collin-Osdoby, P., L. Rothe, F. Anderson, et al. 2001. Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. Journal of Biological Chemistry 276: 20659-20672.
15. Buckner JH. Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nature Reviews Immunology 10: 849-859.
16. Evans, K.E., and S.W. Fox. 2007. Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus. BMC Cell Biology 8: 4. (Pubitemid 46210959)
17. El-Hajj Fuleihan, G., M. Nabulsi, H. Tamim, et al. 2006. Effect of vitamin D replacement on musculoskeletal parameters in school children: A randomized controlled trial. Journal of Clinical Endocrinology and Metabolism 91: 405-412. (Pubitemid 43236902)
18. Clarke, B. 2008. Normal bone anatomy and physiology. Clinical Journal of the American Society of Nephrology 3(Suppl 3): S131-S139.
19. Ershler, W.B., and E.T. Keller. 2000. Age-Associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annual Review of Medicine 51: 245-270. (Pubitemid 30216036)
20. Gabay, C., and I. Kushner. 1999. Acute-phase proteins and other systemic responses to inflammation. The New England Journal of Medicine 340: 448-454. (Pubitemid 29084777)
21. Clowes, J.A., B.L. Riggs, and S. Khosla. 2005. The role of the immune system in the pathophysiology of osteoporosis. Immunology Reviews 208: 207-227. (Pubitemid 41746395)
22. Bendixen, A.C., N.K. Shevde, K.M. Dienger, et al. 2001. IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-Activated receptor gamma 1. Proceedings of the National Academy of Sciences of the United States of America 98: 2443-2448. (Pubitemid 32209501)
23. Takeuchi, Y., S. Watanabe, G. Ishii, et al. 2002. Interleukin-11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice. Journal of Biological Chemistry 277: 49011-49018. (Pubitemid 35470873)
24. Palmqvist, P., E. Persson, H.H. Conaway, et al. 2002. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. Journal of Immunology 169: 3353-3362. (Pubitemid 35013185)
25. Ding, C., V. Parameswaran, R. Udayan, et al. 2008. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: A longitudinal study. Journal of Clinical Endocrinology and Metabolism 93: 1952-1958. (Pubitemid 351656543)
26. Scheidt-Nave, C., H. Bismar, G. Leidig-Bruckner, et al. 2001. Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. Journal of Clinical Endocrinology and Metabolism 86: 2032-2042. (Pubitemid 32472916)
27. McKane, W.R., S. Khosla, J.M. Peterson, et al. 1994. Circulating levels of cytokines that modulate bone resorption: Effects of age and menopause in women. Journal of Bone and Mineral Research 9: 1313-1318. (Pubitemid 24238362)
28. Kania, D.M., N. Binkley, M. Checovich, et al. 1995. Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density. Journal of the American Geriatrics Society 43: 236-239.
29. Abrahamsen, B., V. Bonnevie-Nielsen, E.N. Ebbesen, et al. 2000. Cytokines and bone loss in a 5-year longitudinal study - hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: The Danish Osteoporosis Prevention Study. Journal of Bone and Mineral Research 15: 1545-1554. (Pubitemid 30484524)
30. Kuroki, T., M. Shingu, Y. Koshihara, et al. 1994. Effects of cytokines on alkaline phosphatase and osteocalcin production, calcification and calcium release by human osteoblastic cells. British Journal of Rheumatology 33: 224-230. (Pubitemid 24089771)
31. Uitterlinden, A.G., Y. Fang, J.B. Van Meurs, et al. 2004. Genetics and biology of vitamin D receptor polymorphisms. Gene 338: 143-156. (Pubitemid 39094759)
32. Gao, Y., F. Grassi, M.R. Ryan, et al. 2007. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. The Journal of Clinical Investigation 117: 122-132. (Pubitemid 46048459)
33. Cantorna, M.T. 2010. Mechanisms underlying the effect of vitamin D on the immune system. Proceedings of the Nutrition Society 69: 286-289.
34. Goswami, J., N. Hernandez-Santos, L.A. Zuniga, et al. 2009. A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss. European Journal of Immunology 39: 2831-2839.
35. Johnson, R.B., N. Wood, and F.G. Serio. 2004. Interleukin-11 and IL-17 and the pathogenesis of periodontal disease. Journal of Periodontology 75: 37-43. (Pubitemid 38312768)
36. Van Bezooijen, R.L., H.C. Farih-Sips, S.E. Papapoulos, et al. 1999. Interleukin-17: A new bone acting cytokine in vitro. Journal of Bone and Mineral Research 14: 1513-1521. (Pubitemid 29416677)
37. Chabaud, M., J.M. Durand, N. Buchs, et al. 1999. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis and Rheumatism 42: 963-970. (Pubitemid 29215007)